Abstract
Men attending the urology clinic for male-LUTS/nocturia had higher brachial-ankle pulse wave velocity (baPWV). This association was more pronounced in men <70 years old. Men presented with both nocturia ≥3 times/night and baPWV >1800 cm/sec showed a significant predilection for developing major adverse cardiovascular events (MACE).
Introduction
Nocturia, the need to wake up at night to urinate, is one of the most common and bothersome lower urinary tract symptoms (LUTS) in men. While traditionally viewed as a urological issue, emerging evidence suggests it may be a marker for systemic health problems, including hypertension and coronary artery disease. This study investigates the link between nocturia and central arterial stiffness (CAS)—a hallmark of vascular aging—and its potential to predict major adverse cardiovascular events (MACE) such as heart attacks and strokes.
Methodology
The researchers conducted a two-phase study involving 246 men (mean age 68.1) at a tertiary urological center in Hong Kong.
- Cross-sectional analysis: Brachial-ankle pulse wave velocity (baPWV) was measured as a non-invasive surrogate for arterial stiffness. These measurements were correlated with the International Prostate Symptom Score (IPSS), specifically focusing on nocturia frequency.
- Longitudinal observation: Patients were followed for a median of 27.5 months to track the occurrence of MACE using electronic hospital records.
Multivariate logistic regression and Cox proportional hazard regression were used to identify predictors of arterial stiffness and future cardiovascular events.
Key Results and Insights
Nocturia vs. Total Urinary Symptoms
A critical finding of the study was that the total IPSS score did not correlate with arterial stiffness. Only the specific symptom of nocturia showed a significant association. This suggests that nocturia is a distinct systemic indicator rather than a byproduct of general urinary tract issues.
Accelerated Vascular Aging
The association between nocturia and arterial stiffness was particularly pronounced in men under 70. Frequent nighttime urination in this demographic may signal that a patient's "vascular age" is significantly higher than their chronological age.
Predictors of Arterial Stiffness and MACE
The study identified several independent predictors of significant arterial stiffness (baPWV >1800 cm/sec):
- Age ≥ 70 (OR: 2.70)
- Diabetes (OR: 2.26)
- Hypertension (OR: 1.95)
- Nocturia ≥ 3x/night (OR: 1.75)
Furthermore, the risk of MACE increased sharply when nocturia frequency reached 3 or more times per night. The hazard ratio for MACE in patients with baPWV >1800 cm/sec was 5.16, while nocturia ≥ 3x/night carried a hazard ratio of 2.87.
Discussion and Clinical Implications
The study suggests that adding nocturia frequency and baPWV measurements to standard cardiovascular risk models significantly improves the accuracy of MACE prediction. The "3x" threshold for nocturia appears to be a critical clinical marker for both arterial stiffness and future cardiovascular risk.
While the study is limited by its single-center design and self-reported nocturia data, it highlights the importance of a multidisciplinary approach. Urologists seeing patients for nocturia may be in a unique position to identify men at high risk for cardiovascular disease who might otherwise be overlooked.
Conclusion
Nocturia is more than a urological annoyance; it is a significant marker for cardiovascular health. Men experiencing frequent nocturia, especially those under 70, should be considered for cardiovascular screening to assess arterial stiffness and overall heart health.
Summary updated